CK Life Sciences Int'l. (HKG:0775) appointed Lance Richard Lee Yuen as its chief executive officer and vice president with effect from Friday, Sept. 20, a same-day filing with the Hong Kong Exchange said.
The appointment came following the re-designation of the former CEO Yu Ying Choi, Alan Abel as the deputy chairman of the biotechnology company.
The company's shares closed over 1% higher on Friday.
Price (HKD): $0.36, Change: $+0.0050, Percent Change: +1.41%
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.